The clinical benefit of instituting a prospective clinical community-acquired respiratory virus surveillance program in allogeneic hematopoietic stem cell transplantation.

Respiratory tract infections are the second leading cause of mortality and morbidity worldwide1 and community acquired respiratory viruses (CARV) are the most common cause2. This statistic and the recent 2009 H1N1 influenza pandemic have raised awareness in national and transnational health authorities who support developing CARV epidemiological survey systems3 –6. These monitoring activities definitely contribute to health improvement and are extremely useful for national policy makers in identifying groups at high risk and for selecting influenza strains for yearly vaccine production.

Source: Journal of Infection - January 19, 2020 Category: Infectious Diseases Authors: Jos éLuis Piñana, Juan Montoro, Carla Aznar, Ignacio Lorenzo, MaríaDolores Gómez, Manuel Guerreiro, Carlos Carretero, EvaMaría González-Barberá, Aitana Balaguer-Roselló, Rosa Sanz, Miguel Salavert, David Navarro, MiguelA. Sanz, Guillermo Sanz, Jai Source Type: research